International Biotechnology Ord (LSE:IBT) - Overview

Investment Trust Report

International Biotechnology Trust IBT

Closing Price

1 Day Change

As of 26/10/2016

Last Close531.75
52-Wk Range380.00 - 574.00
Tot Assets Mil223.74
Mkt Cap Mil199.66
Yield %0.00
Estimated Nav590.00
Discount % %-9.87
12M Avg Disc %-12.48
Last Actual NAV593.08
Last NAV Date25/10/2016

Share Price Performance (GBP)

Key Statistics (GBP)
Total Assets223.743m
Net Assets223.743m
Market Capitalisation199.661m
Gross Gearing100%
Net Gearing100%
Average Daily Shares Traded (1 Yr)0.050m
Average Daily Value Traded (1 Yr)0.236m
Ongoing Charge (2015)1.48%
Legal StructureClosed End Fund
Traded CurrencyGBP
Launch Date31 Mar 1994
Financial Year EndAug 2017
Next AGMDec 2016
NAV FrequencyDaily
Dividend FrequencySemi-annually
Valuation Statistics
 26/10/20161 Yr High1 Yr Low
Category Discount-6.23-0.49-12.33
Z-Statistics (1Yr)1.26  

Total Returns (GBP) 26/10/2016

 Chg (%)  
More ...
Cat Price-1.88
Cat NAV-2.13
Director Dealings
18/02/2016PurchaseMr. Jim Horsburgh421.715,00021,086.00
25/01/2016PurchaseMs. Caroline Gulliver468.002,50011,700.00

Morningstar Rating™

4 Stars

Morningstar® Category

Sector Equity Biotechnology


Fund Benchmark

Nasdaq Biotech Index

Morningstar® Benchmark

Fund Structure
Share Type# of Shares
Ordinary Share37.548m

Investment Objective

To achieve capital growth through investing in high growth, development stage biotechnology companies.
Kate Bingham01/01/2005
Ailsa Craig01/01/2005
Carl Harald Janson02/09/2013


John Aston, OBE, Dr Veronique Bouchet, Alan Clifton, Caroline Gulliver, Jim Horsburgh
Fund prices are updated every weekday after the close of trading and before 11 p.m. wherever possible. All figures are as at Last Close, on a cum income basis with debt valued at fair and in traded currency unless otherwise stated (we do not fair value debt for split capital trusts). Performance returns are presented in British Pounds (GBP) and calculated on a capital only basis with debt valued at par.
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2016 Morningstar. All rights reserved.